Alps Advisors Inc Halozyme Therapeutics, Inc. Transaction History

Alps Advisors Inc

  • $14.1 Billion
  • Q1 2024

A detailed history of Alps Advisors Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 8,433 shares of HALO stock, worth $432,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,433
Previous 8,514 0.95%
Holding current value
$432,612
Previous $314,000 9.24%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$33.68 - $41.95 $2,728 - $3,397
-81 Reduced 0.95%
8,433 $343,000
Q4 2023

Feb 14, 2024
SELL
$33.32 - $42.1 $16,193 - $20,460
-486 Reduced 5.4%
8,514 $314,000
Q3 2023

Nov 14, 2023
BUY
$36.46 - $44.03 $328,140 - $396,270
9,000 New
9,000 $343,000
Q4 2022

Feb 14, 2023
SELL
$40.06 - $59.44 $1,241 - $1,842
-31 Reduced 0.4%
7,638 $434,000
Q3 2022

Nov 14, 2022
BUY
$38.53 - $51.78 $295,486 - $397,100
7,669 New
7,669 $303,000
Q1 2022

May 16, 2022
SELL
$31.97 - $41.06 $286,419 - $367,856
-8,959 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$31.82 - $40.75 $5,727 - $7,335
180 Added 2.05%
8,959 $360,000
Q3 2021

Nov 15, 2021
BUY
$38.47 - $46.42 $337,728 - $407,521
8,779 New
8,779 $357,000
Q4 2019

Feb 07, 2020
SELL
$14.93 - $19.53 $4.36 Million - $5.7 Million
-291,765 Closed
0 $0
Q3 2019

Nov 04, 2019
SELL
$15.2 - $17.69 $176,198 - $205,062
-11,592 Reduced 3.82%
291,765 $4.53 Million
Q2 2019

Aug 07, 2019
SELL
$14.75 - $17.26 $692,556 - $810,408
-46,953 Reduced 13.4%
303,357 $5.21 Million
Q1 2019

May 01, 2019
SELL
$13.94 - $17.58 $149,130 - $188,070
-10,698 Reduced 2.96%
350,310 $5.64 Million
Q4 2018

Feb 04, 2019
BUY
$13.33 - $18.66 $1.03 Million - $1.45 Million
77,631 Added 27.39%
361,008 $5.28 Million
Q3 2018

Oct 25, 2018
BUY
$16.68 - $18.41 $897,567 - $990,660
53,811 Added 23.44%
283,377 $5.15 Million
Q2 2018

Aug 02, 2018
BUY
$16.87 - $20.3 $1.21 Million - $1.46 Million
71,818 Added 45.53%
229,566 $3.87 Million
Q2 2018

Jul 25, 2018
SELL
$16.87 - $20.3 $963,428 - $1.16 Million
-57,109 Reduced 26.58%
157,748 $3.2 Million
Q1 2018

May 01, 2018
BUY
$17.06 - $21.2 $974,279 - $1.21 Million
57,109 Added 36.2%
214,857 $4.21 Million
Q4 2017

Feb 05, 2018
BUY
$16.75 - $20.8 $301,232 - $374,067
17,984 Added 12.87%
157,748 $3.2 Million
Q3 2017

Nov 03, 2017
BUY
$11.76 - $17.4 $1.64 Million - $2.43 Million
139,764
139,764 $2.43 Million

Others Institutions Holding HALO

# of Institutions
441
Shares Held
122M
Call Options Held
216K
Put Options Held
140K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.15B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email